Bafna Pharmaceuticals Ltd.

Financial

	Bafna Pharma	IndoAmerican Advance	Syschem (India)
Operational Metrics
Financials
5 yr Average ROE	-52.11 %	-12.16 %	-19.23 %
5yr average Equity Multiplier	3.77	1.07	6.28
5yr Average Asset Turnover Ratio	0.42	0.15	1.15
5yr Avg Net Profit Margin	-36.55 %	-36.65 %	-1.61 %
Price to Book	3.33	n/a	1.8
P/E	39.64	n/a	358.15
5yr Avg Cash Conversion Cycle	0.18 Days	0.0	-2.55 Days
Inventory Days	87.65 Days	0.0	94.02 Days
Days Receivable	132.64 Days	0.0	86.28 Days
Days Payable	210.48 Days	167.71 Days	176.28 Days
5yr Average Interest Coverage Ratio	-5.68	-55.68	-19.05
5yr Avg ROCE	-11.61 %	-12.15 %	-3.72 %
5yr Avg Operating Profit Margin	-21.98 %	-72.03 %	0.88 %
5 yr average Debt to Equity	1.41	0.0	0.82
5yr CAGR Net Profit	12.0 %	n/a	n/a
5yr Average Return on Assets	-16.11 %	-11.02 %	-1.4 %
Shareholdings
Promoter Holding	75.0 %	0.97 %	57.02 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-15.42 %	-17.4 %	40.68 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0